Amylyx Pharmaceuticals
The Associate Director, Commercial Training and Development will lead the design, development, and delivery of onboarding, disease-state, product, and advanced skills training for Amylyx customer-facing teams. This role partners with cross-functional leaders to translate commercial strategy into practical learning experiences and drive observable field behavior. The position supports launch readiness and evaluates training effectiveness to improve performance across the organization.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Lead, Disease State Training
AstraZeneca
Lead, Disease State Training
AstraZeneca
Director, Global Commercial Training & Sales Enablement
Baxter International
Associate Director, Commercial Effectiveness & Training
Sobi
Manager Commercial Training and Education (Mississauga, Ontario, Canada)
Smith & Nephew
Director, Global Commercial Systems Training & Onboarding
Siemens Healthineers